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Causative factors for childhood cancers,
some of which are apparently increasing in
the United States, remain largely elusive (1).
Furthermore, evidence is increasing for
inﬂuence of perinatal circumstances on risk
of adult cancers (2–4). Risk of childhood
cancer has been associated with preconcep-
tional parental exposures in numerous epi-
demiologic studies; paternal occupational
exposure to metals has been repeatedly
implicated (1,5–7). Preconceptional carcino-
genesis by chemicals and radiation is well
established in animal models (1,7,8).
Characteristics of preconceptional carcino-
genesis in animal models, including non-
Mendelian inheritance patterns (9), rates
that are much higher than expected for point
mutation (10), and absence of mutations in
cancer genes (11,12), have led us to propose
that the mechanism is epigenetic (13,14).
The operation of a novel mechanism is also
suggested by reports of high-frequency pre-
conceptional effects on nontumor end
points, some of them adaptive rather than
toxicologic, for mammals, invertebrates, and
plants (15,16).
In a test in mice of preconceptional car-
cinogenicity of metals present in welding
fumes, we observed a signiﬁcant effect with
chromium(III) chloride (CrCl3) (13). A
more extensive study conﬁrmed this ﬁnding,
revealing that endocrine and secretory tissues
were prominently targeted in the offspring
(14). This led to the hypothesis that alter-
ations in hormones in the offspring could be
part of the mechanism of preconceptional
carcinogenesis.
To test this hypothesis, we treated male
mice with chromium(III) chloride and
mated them 2 weeks later, following the pre-
conceptional carcinogenesis protocol. We
assessed the offspring at 10 weeks of age for
serum levels of corticosterone, glucose, and
insulin-like growth factor 1 (IGF1), under
closely controlled conditions. We observed
highly signiﬁcant increases in corticosterone
and glucose in the sera of offspring of
chromium(III)-treated fathers.
Materials and Methods
We injected NIH Swiss NCR male mice, 8
weeks old, from the Frederick Cancer
Research Facility Animal Production 
Area, intraperitoneally with 1 mmol/kg
CrCl3•6H2O (Aldrich Chemical Co.,
Milwaukee, WI) in 0.9% NaCl. We adjusted
the original CrCl3 solutions, which were
highly acidic, to pH 4.0 by adding NaOH.
Controls received saline that had been
adjusted to pH 4.0 by addition of HCl. We
injected the male mice in the afternoon in
experiment 1 and in the morning in experi-
ment 2. We maintained mice in a facility
accredited by the American Association for
Accreditation of Laboratory Animal Sciences.
We bred each male to an 8-week-old female
of the same strain, 2 weeks after treatment, as
in previous studies (13,14).
We developed a euthanasia method to
minimize increases in serum corticosterone
due to the procedure. We acclimatized the
mice to the laboratory and handled them for
several minutes before exsanguination via
cervical incision. A separate study showed
that mice euthanized in this way had lower
and more uniform serum corticosterone
compared with those used directly from the
animal room (data not shown). In experi-
ment 1, we euthanized the fathers after
breeding was complete, in the morning, an
average of 26.2 ± 0.8 days after treatment for
chromium-treated mice and 25.2 ± 0.8 days
for control mice. The offspring were eutha-
nized at 68–72 days old, between 0900 and
1100 hr, with treated-group and control
mice included in each set.
In preparation for experiment 2, we
determined the time in the morning during
which serum corticosterone levels were con-
stant. For untreated male mice (10 per
group), corticosterone values were 29.4 ± 3.2
(± SE) ng/mL at 1000 hr and 30.1 ± 2.6
ng/mL at 1100 hr, so in experiment 2, male
offspring were euthanized between 1000 and
1100 hr. Females showed 248 ± 30 ng/mL
corticosterone at 1100 hr and 236 ± 38
ng/mL at 1300 hr, and so were euthanized
between 1100 and 1200 hr.
We followed the fathers for experiment 2
for weight changes and euthanized them 10
weeks after treatment; at this time point, we
observed no significant differences between
groups regarding serum corticosterone, glu-
cose, or IGF1 (data not shown).
AniLytics, Inc. (Rockville, MD, USA)
analyzed serum glucose, corticosterone, and
IGF1 with kits for glucose/hexokinase
(Boehringer Mannheim, Indianapolis, IN),
125I-corticosterone (ICN Pharmaceuticals,
Costa Mesa, CA), and rat IGF1 (Diagnostic
Systems Laboratories, Houston, TX), respec-
tively. Statistical analysis of the data for these
parameters used simple data descriptive tech-
niques, mixed-models analysis of variance
(ANOVA), analysis of covariance, regression
analysis, and post hoc tests. In particular, we
considered chromium(III)-treated and con-
trol father mice as random factors in mixed,
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Preconceptional carcinogenesis occurs in animals and is suspected for humans—for example, after
occupational metals exposure. Several characteristics in animal models, including high frequency
and non-Mendelian inheritance patterns, have suggested an epigenetic mechanism, possibly
involving hormone changes in offspring. To test this hypothesis, we treated male mice with
chromium(III) chloride, a preconceptional carcinogen, 2 weeks before mating, in two separate
experiments. Their 10-week-old offspring showed highly significant increases in average serum
corticosterone and glucose, compared with control offspring. Average serum levels of insulin-like
growth factor 1 (IGF1) showed more modest possible increases. A previous microarray experi-
ment identiﬁed hepatic insulin-like growth factor binding protein 1 (IGF BP1) gene expression as
consistently changed in correlation with serum corticosterone levels. In the present study, hepatic
IGF BP1 mRNA correlated with serum IGF1 in male offspring of chromium-treated fathers, but
not in controls; serum glucose correlated positively with hepatic IGF BP1 in chromium-group
offspring but negatively in controls. These results support the hypothesis that preconceptional
exposure effects may alter hormones, metabolism, and control of tissue gene expression, probably
through epigenetic mechanisms. Risk of neoplasia may be inﬂuenced by these changes. Key words:
chromium(III), corticosterone, insulin-like growth factor 1, insulin-like growth factor binding
protein 1, offspring, paternal, preconceptional, stress, transgenerational. Environ Health Perspect
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http://ehpnet1.niehs.nih.gov/docs/2002/110p801-804cheng/abstract.htmlhierarchically nested designs. We trans-
formed analyses of corticosterone measures
to their common logarithms to satisfy
homogeneity of variance requirements in the
ANOVAs. We performed analyses of glucose
measures on the raw data. We made infer-
ences regarding significant differences
among corticosterone, glucose, and other
parameters in male and female offspring as a
result of analyses taking the fathers as the
treated experimental unit.
We evaluated hepatic mRNA for insulin-
like growth factor binding protein 1 (IGF
BP1) from selected mice by semiquantitative
reverse transcriptase–polymerase chain reac-
tion (RT-PCR). The average serum values
for control and chromium groups, respec-
tively, were, for corticosterone, 44 ± 9 and
102 ± 17 ng/mL; for glucose, 217 ± 6 and
238 ± 6 mg/dL; and for IGF1, 282 ±13 and
323 ± 26 ng/mL. Thus, these mice were rep-
resentative of the larger population of the
study. The primer pair for IGF BP1 PCR
was CTCTGCATGCCCTCACC (forward)
and CCAGCAGCTGTTCCTCT (reverse)
(17). Linear amplification occurred over
cycles 15–27; we used 21 cycles. We quanti-
ﬁed the IGF BP1 expression in two RT-PCR
assays and pooled the results by normalizing
each value to the lowest value in that assay.
For statistical evaluation of the relationships
between IGF BP1 expression and serum
IGF1 and glucose, we performed regression
analyses to determine the signiﬁcance of dif-
ferences of line slopes from zero. In addition,
we performed comparative regression analy-
ses for offspring of control and
chromium(III)-treated fathers. We carried
out analyses of covariance to determine
whether regression lines in each group were
homogeneous and to evaluate the signifi-
cance of differences in slopes and intercepts.
Results
In the first experiment, 1 mmol/kg
chromium(III) chloride proved signiﬁcantly
toxic, as indicated by failure of some treated
males to father offspring (11/20 bred vs.
18/20 vehicle-treated controls, p = 0.031)
and by significantly increased serum corti-
costerone and decreased serum glucose at
25–26 days after treatment (Figure 1A,B).
We assessed the offspring of the males that
succeeded in breeding at 10 weeks old for
serum corticosterone and glucose. All mice
were euthanized in the morning and both
treatment and control group mice were
included each day.
The female offspring of the chromium
(III)-treated fathers had markedly higher
average serum corticosterone compared with
offspring of vehicle-treated fathers (Figure
1C). Average serum glucose also showed a
highly significant increase (Figure 1D).
These differences remained significant after
statistical consideration of litter membership,
day of euthanasia, and exact age. Thus, we
observed a shift toward higher serum corti-
costerone over most or all of the female off-
spring from the treated fathers. We noted no
signiﬁcant differences in the male offspring.
Chromium(III) chloride hexahydrate does
not always exhibit this toxicity when adminis-
tered to male mice (13,14). We found that
chromium(III) toxicity related in part to the
time lapsing between preparation and injec-
tion of the solution and could involve
decreases in pH. In a second experiment, we
injected solution within 30 min of prepara-
tion, in the morning, rather than after about
4 hr and in the afternoon, as in the ﬁrst study.
In addition, we added a second dose level, 0.1
mmol/kg. We observed no signiﬁcant effects
on breeding, indicating less toxicity. One
male in each group of 10 failed to father off-
spring. In addition, one male in the high-dose
chromium group and two males in the low-
dose chromium group fathered litters that did
not survive to weaning. Nevertheless, some
residual toxic stress was evident, as indicated
by the signiﬁcantly lower body weights in the
high-dose group, for example, at 3 days after
treatment, 30.2 ± 0.7 g for the controls versus
27.3 ± 0.5 g for the high-dose chromium-
treated fathers (p = 0.0027).
Experiment 2 offspring were euthanized
within a 1-hr time span in the morning,
when corticosterone levels had been deter-
mined in a separate study to be at a steady
minimum (see “Materials and Methods”).
The results for the offspring of this experi-
ment confirmed those for the female off-
spring of the ﬁrst trial, and in addition, we
saw similar effects in the male offspring. We
found a highly signiﬁcant, 2-fold increase in
average corticosterone in the offspring of
both sexes after the higher dose (Figure 2A).
The male offspring showed an apparent cor-
ticosterone increase after the lower dose as
well (Figure 2A), although this fell short of
statistical significance. We found a signifi-
cant increase in serum glucose in the male
offspring of the fathers treated with the
higher chromium dose (Figure 2B) and a
small increase in serum glucose in the
females, although this fell short of signifi-
cance. The statistical methods used, involv-
ing mixed-model ANOVAs, conﬁrmed that
the increases in serum corticosterone and
glucose were not due to large changes in a
few offspring.
In another study (18), we found that
chromium high-dose treatment of fathers
resulted in significantly increased IGF1 in
offspring, and microarray analysis of gene
expression in the offspring livers revealed a
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Figure 1. Twenty Swiss male mice, assessed ~25 days after intraperitoneal treatment with 1 mmol/kg
Cr(III)/kg body weight, showed a signiﬁcant increase (p = 0.0098; Student’s t-test) in average serum corti-
costerone (A) and a signiﬁcant decrease (p = 0.0004; t-test with Welch correction) in serum glucose (B)
compared with 20 mice treated with acidiﬁed saline vehicle (control). The 41 female offspring of the Cr(III)-
treated fathers showed signiﬁcant increases in average serum corticosterone (p = 0.021) (C) and glucose
(p = 0.002) (D) compared with the 45 controls. We obtained p-values for signiﬁcance for offspring values by
ANOVA using mixed models with random nested factors; the fathers were the unit of treatment. We per-
formed corticosterone analyses on log-transformed data to maximize homogeneity but display results in
direct format.
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C Ddecreased expression of IGF BP1 compared
with controls. IGF1 is a negative regulator of
IGF BP1 expression (19). In experiment 2 of
the present study, IGF1 was moderately ele-
vated in the offspring after the high-dose
chromium compared with controls, 309 ± 15
ng/mL versus 274 ± 14 ng/mL for females (p
= 0.090) and 285 ± 12 ng/mL versus 265 ± 6
ng/mL for males (p = 0.14). We further ana-
lyzed livers of representative offspring from
experiment 2 for IGF BP1 mRNA by semi-
quantitative RT-PCR. We found no marked
differences in female offspring. In the male
offspring, normalized IGF BP1 expression
was again somewhat lower in the chromium
high-dose group compared with controls, 3.0
± 0.3 relative ﬂuorescence units versus 4.6 ±
1.0 (p = 0.069, one-tailed test). The normal-
ized relative IGF BP1 hepatic expression lev-
els showed significant negative correlation
with serum IGF1 in the chromium group but
not in the controls (Figure 3B). Most striking,
serum glucose was positively associated with
IGF BP1 in the chromium group but nega-
tively associated in the controls (Figure 3C).
Discussion
The ﬁndings of the two independent experi-
ments reported here conﬁrm the hypothesis
that preconceptional effects can involve
alterations in hormone levels in the off-
spring. The increase in serum corticosterone
in the offspring of the chromium(III)-treated
fathers was marked and highly signiﬁcant in
both experiments. A more pronounced pre-
conceptional effect occurred in the second
experiment. This may have related to the
different times of day used for paternal treat-
ment and/or to the fact that most of the
treated fathers from experiment 2 produced
surviving offspring. Signiﬁcant alterations in
serum glucose, well known to be regulated
by glucocorticoids, confirmed the biologic
significance of the difference in corticos-
terone levels.
The measurements of IGF BP1 expres-
sion in liver provided additional evidence for
the persistence of effects of paternal exposure
in the tissues of offspring. Consistent with
downregulation of IGF BP1 expression by
IGF1, we observed a significant negative
relationship between serum IGF1 and
hepatic IGF BP1 mRNA in selected male
offspring of the chromium-treated fathers.
However, this relationship was not found in
the control male offspring. The differences in
slopes and intercepts for the regression lines
for the two groups were highly significant.
We observed even more striking differences
for the relationship between serum glucose
and relative hepatic expression of IGF BP1,
which was strongly positive for the offspring
of the chromium-treated fathers and strongly
negative for control offspring.
A possible interpretation of these com-
plex interrelationships derives from the
known counterregulatory role of IGF BP1 in
glucose homeostasis (20). The 2-fold increase
in average serum corticosterone in the male
offspring of chromium-treated fathers may
have tended to increase IGF BP1 synthesis;
correlation between corticosterone and IGF
BP1 mRNA levels was close to significance
for these animals (p = 0.19; data not shown).
IGF BP1 gene expression is known to be reg-
ulated by glucocorticoids (19). Sequestration
of IGF1 by the IGF BP1 might then have
increased serum glucose due to decreased tis-
sue uptake, and hence the strong positive
correlation between IGF BP1 and serum glu-
cose, as shown in Figure 3C. Countering
these effects could have been negative feed-
back regulation of IGF BP1 expression by
the elevated IGF1, as shown in Figure 3B,
resulting in the small net decrease in IGF
BP1 expression. In the control animals with
lower corticosterone and IGF1, by contrast,
the known negative control of IGF BP1 by
glucose predominated (20), and feedback
regulation by IGF1 was not dominant. More
experiments are required to test these ideas.
In any event, our data indicate that the com-
plex relationships among IGF BP1, glucose,
IGF1, and possibly corticosterone can be
inﬂuenced by paternal exposures.
Articles • Preconceptional Cr(III) affects hormones in offspring
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Figure 2. In a second experiment, we treated fathers with freshly prepared CrCl3 at 0.1 mmol/kg (low) or 1
mmol/kg (high) or acidiﬁed saline vehicle (control). We mated them after 2 weeks and assessed the off-
spring at 10 weeks of age. Numbers of offspring were 36 control, 37 low-dose, and 30 high-dose females
and 38 control, 26 low-dose, and 40 high-dose males. p-Values indicate the significance of differences
between vehicle controls and the high chromium dose: (A) Females, p = 0.0001; males, p = 0.0023. (B) Both
females and males, p = 0.0018. 
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Figure 3. Effect of paternal exposure to 1 mmol/kg CrCl3 in experiment 2 on relationship between hepatic IGF BP1 mRNA and serum IGF1 and glucose in selected male
offspring. We made measurements on 16 control offspring from 9 fathers and 15 chromium-group offspring from 7 fathers. (A) Representative RT-PCR for IGF BP1 mRNA
in offspring livers. Chromium-group offspring were numbers 201, 204, 206, 208, 210, 211, 215, 216, 217, and 218. Control offspring were numbers 202, 203, 205, 207, 209, 212,
213, and 214. (B) Correlation of serum IGF1 with hepatic IGF BP1 mRNA. The p-value, p = 0.050, is the signiﬁcance of the difference of the negative slope for the
chromium-group offspring versus zero. The regression lines for the two groups differed signiﬁcantly regarding their intercepts (p = 0.017) and slopes (p = 0.018). (C)
Correlation of serum glucose with hepatic IGF BP1 mRNA. The p-values, p = 0.0051 (solid line) and p = 0.019 (dashed line), are the signiﬁcances of the differences of the
slopes from zero. The regression lines had signiﬁcantly different intercepts (p= 0.033) and, importantly, signiﬁcantly different slopes in opposite directions (p= 0.0006).Whether the observed differences in
serum corticosterone, glucose, and IGF1 are
sufficient to account for known preconcep-
tional effects on neoplasms and other phe-
nomena requires further study. The ﬁndings
are consistent with this interpretation. High-
caloric diets increase tumor incidence in
rodents and are suspected to have a similar
role regarding cancer and other diseases in
humans, and increases in serum glucose and
IGF1 are correlated (21–24). IGF1 and IGF
BP1 have been repeatedly implicated in
human cancer risk (25–28). Corticosteroids
have a complex, wide range of positive and
negative effects, depending on concentration,
duration, physiologic context, and tissue type
(29). Both stimulatory and suppressive effects
of corticosteroids on the immune system,
metabolism, and other hormones have been
described (29). Correspondingly, corticos-
teroids may have either positive or negative
association with tumor development or
behavior, depending on the cancer type
(30,31). This is consistent with the fact that
previously observed preconceptional effects
have included both increases and decreases in
incidences of specific neoplasms in the off-
spring (14,32).
Beyond neoplasia, transgenerational
effects have been observed on reproduction,
metabolism, immunity, and behavior (15), all
likely targets of neuroendocrine disruption.
Thus, transgenerational phenomena might
influence risk of not only cancer but also
other conditions such as obesity, diabetes, and
asthma. We propose a further, broader
hypothesis, that what we have uncovered is
not primarily a toxicologic phenomenon but
an adaptive one: Stressed fathers prepare their
offspring for a stressful environment by some-
how preprogramming them to upregulate
serum corticosterone. The wide-ranging types
of transgenerational effects that have been
described across phyla (15,16) suggest that
this adaptive communication between the
physiology of parent and offspring may be a
general biologic phenomenon.
The mechanism of the transgenerational
effect on serum corticosterone, glucose, and
IGF1 is unknown at present. The fact that
most or all of the offspring were affected argues
against a mutational effect. Furthermore,
under the conditions that we employed, we did
not detect chromium(III), which enters cells
poorly, in the sperm even with highly sensitive
techniques, although we found low levels in
interstitial tissue of the testis (33,34). An indi-
rect, epigenetic effect seems likely. It is well
known that controls may be imposed on gene
expression during gametogenesis, in the par-
ent-speciﬁc imprinting phenomenon (35), in
which change in gene methylation seems to be
part of the mechanism. Further study of this
novel phenomenon will be of considerable
basic interest as well as relevant to public health
concerns.
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